Skip to content

Turkish Medical Index Blog | Turkish Medical Index

Business Cultures: Belgium

Business Cultures

Business Cultures: Belgium

Turkish Medical Index 04 November 2026 turkishmedicalindex.com 4 min read
At a glanceBelgium is one of Europe's most strategically important medical device markets — not because of its size (11 million people), but because of its concentration of EU institutional power, international healthcare organisations, and Medtech Europe's Brussels headquarters. Belgian business culture reflects the country's complex trilingual identity: Dutch-speaking Flanders, French-speaking Wallonia, and bilingual Brussels each have distinct commercial cultures. Understanding this linguistic and cultural complexity — while engaging Belgium's substantive hospital procurement and EU institutional healthcare networks — is essential for Turkish exporters targeting the EU market.
Part 01

Key Cultural Traits in Business

Linguistic Complexity — Three Markets in One

Belgium has three official language communities: Dutch-speaking Flanders (north), French-speaking Wallonia (south), and bilingual Brussels. Business culture differs meaningfully between them — Flemish business culture resembles the Netherlands (direct, efficient, punctual); Walloon French business culture resembles France (relationship-oriented, formal, hierarchical). Brussels is genuinely bilingual in commercial settings. Know your counterpart's community and adapt language and style accordingly.

Consensus and Thoroughness

Belgian decision-making is typically consensus-oriented and thorough. Hospital procurement committees include multiple stakeholders — clinical directors, biomedical engineers, procurement officers, and hospital management. Decisions take longer than in the Netherlands or UK but are rarely reversed once made. Present comprehensive technical documentation; Belgian procurement professionals value depth over brevity.

EU Institutional Proximity

Brussels hosts the European Commission, European Parliament, EFPIA, Medtech Europe, and hundreds of EU healthcare policy institutions. Belgium's commercial healthcare culture is influenced by this proximity — Belgian procurement officers are often well-versed in EU regulatory frameworks, MDR compliance, and European healthcare policy. Regulatory credibility and EU MDR compliance are strong commercial signals.

Formality in Initial Meetings

Initial business meetings in Belgium are formal — proper titles (Dr., Ir., Prof.) are used, business cards exchanged, and agenda adherence expected. Once a relationship is established, Belgian business culture becomes warmer and more collegial. Flemish contacts tend to move to first names faster than Walloon French contacts.

Practicality and Value Focus

Belgian procurement is pragmatic — value for money (not lowest price) is the primary driver. Clinical evidence, service reliability, and total cost of ownership are evaluated carefully. Belgian hospital procurement committees typically include a financial officer who models lifecycle costs — prepare TCO analyses alongside product presentations.

Part 02

Regulatory & Market Access Overview

Belgium follows EU MDR directly as a full EU member state. FAMHP (Federal Agency for Medicines and Health Products) is the national competent authority for post-market surveillance and market surveillance. CE-marked devices can be placed on the Belgian market without separate national registration. Dutch and French labelling is required for devices sold in Belgium (German in the small German-speaking community). An EU Authorised Representative is required for Turkish manufacturers. FAMHP is one of Europe's more active post-market surveillance authorities — maintain robust PMS documentation.

Part 03

Procurement Culture & Key Channels

Belgian hospital procurement operates through the ZNA (Ziekenhuis Netwerk Antwerpen), UZ Leuven, UZ Gent, UZ Brussel, and CHU (Centre Hospitalier Universitaire) systems in Wallonia — Liège, Charleroi, and Namur. Private groups include Chirec, Iris, and Jolimont. The Belgian healthcare system uses DRG-based hospital financing with national collective agreements on reimbursable devices. The federal Nationale Prijs (national price agreements) for reimbursable devices are negotiated centrally. Belgium Purchasing Federations (hospital purchasing groups) coordinate collective procurement across member hospitals.

Part 04

Practical Tips for Turkish Medical Exporters

  • Prepare bilingual (Dutch/French) marketing materials for Belgium — English alone is insufficient for Belgian hospital procurement engagement
  • Medtech Europe (Brussels) events and working groups provide insight into EU regulatory developments and Belgian distributor contacts
  • UZ Leuven and UZ Gent are internationally influential teaching hospitals — a reference installation at either carries EU-wide credibility
  • Flemish distributors typically cover the Netherlands as well — a single Flemish Belgian distributor may give you Dutch market access as an add-on
  • Belgian hospital purchasing federations (UNAMEC, Fedagmed) provide collective access to member hospitals — engage through federation channels for multi-hospital reach
  • TCO modelling: prepare a 5-year total cost of ownership analysis including maintenance, consumables, and training — Belgian procurement committees will ask for it
  • FAMHP PMS requirements: Belgium is an active market surveillance authority — ensure your PMS and PMCF programmes are fully EU MDR compliant before market entry
  • Brussels EU institutions: if your company has regulatory affairs or policy objectives, Brussels offers direct access to EMA, DG SANTE, and Medtech Europe — consider Brussels as a European regulatory affairs hub
Part 05

Key Trade Shows & Events

MEDICA DüsseldorfNovember — primary meeting venue for Belgian medical device distributors
Arab Health DubaiJanuary — Belgian distributors with international portfolios attend
Medtech Europe Brussels EventsYear-round — EU regulatory and policy engagement
BioWin Wallonia Health ClusterAnnual — French-Belgian medtech innovation ecosystem
Part 06

Strategic Takeaway

Belgium rewards linguistic preparation, regulatory depth, and a thorough approach to clinical evidence. For Turkish manufacturers, Belgium's EU institutional proximity makes it a valuable market not only for commercial sales but for EU regulatory intelligence, Medtech Europe policy engagement, and Notified Body relationship building. A Flemish distributor can often extend coverage to the Netherlands; a Walloon distributor connects to French-language European networks. Belgium's 11 million people punch well above their demographic weight in EU healthcare policy influence.